Atea Pharmaceuticals, Inc. SEC filings AVIR
Atea Pharmaceuticals, Inc. has 313 filings in SEC EDGAR's recent list, going back to Dec 11, 2013. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| S-3 | Shelf registration | Nov 7, 2024 | — |
| POS AM | Filing | May 10, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| S-3ASR | Automatic shelf registration | Nov 24, 2021 | — |
| S-8 | Employee stock plan registration | Oct 30, 2020 | — |
| 424B4 | Prospectus | Oct 30, 2020 | — |
| S-1MEF | Filing | Oct 29, 2020 | — |
| S-1/A | Amended registration statement | Oct 26, 2020 | — |
| S-1/A | Amended registration statement | Oct 23, 2020 | — |
| S-1 | Registration statement | Oct 9, 2020 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVIR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1593899
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.